-
Mashup Score: 0Improving cancer registry systems in Asia - 1 year(s) ago
Tomohiro Matsuda, PhD, National Cancer Center, Tokyo, Japan, discusses how cancer registry systems in Asia can be improved. Key points…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Kohei Shitara, MD, National Cancer Center Hospital East, Chiba, Japan, discusses the current state of using predictive biomarkers for immunotherapy…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥 @KoheiShitara of National Cancer Center Hospital East, Japan, discusses which patients with gastric cancer can benefit most from checkpoint inhibitors Watch: 👉https://t.co/gDmqLkRuVn👈 #ESMOAsia22 @myESMO #STCsm #GastricCancer
-
-
Mashup Score: 0VJOncology – The video journal of oncology - 1 year(s) ago
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the awareness and understanding of oncology
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Did you miss #ESMOAsia22 last week? Don't worry! Head to https://t.co/ys1d8pDAKO for all the highlights 🎥 @myESMO https://t.co/LEpNeKtZIA
-
-
Mashup Score: 0RATIONALE-306: Asian subgroup of 1L tislelizumab + chemo vs chemo alone for esophageal SCC - 1 year(s) ago
Ken Kato, MD, PhD, National Cancer Center Hospital, Tokyo, Japan, discusses results from the Asian subgroup of the global, randomized,…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥 Ken Kato of National Cancer Center Hospital, Japan, talks on RATIONALE-306: Asian subgroup of 1L tislelizumab plus chemo vs chemo alone for patients with advanced/metastatic esophageal squamous cell carcinoma Watch: 👉https://t.co/9Ju4L3WdRh👈 #ESMOAsia22 @myESMO #ESOCsm
-
-
Mashup Score: 0Predictive biomarkers for immunotherapy in upper GI cancers - 1 year(s) ago
Kohei Shitara, MD, National Cancer Center Hospital East, Chiba, Japan, discusses a range of predictive biomarkers for the use of…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥 @KoheiShitara of National Cancer Center Hospital East, Japan, talks on predictive biomarkers for immunotherapy in gastrointestinal cancers Watch: 👉https://t.co/MqC2dAsyvM👈 #ESMOAsia22 @myESMO
-
-
Mashup Score: 0
Tomohiro Matsuda, PhD, National Cancer Center, Tokyo, Japan, explains the RARECAREnet-Asia collaboration. Rare Cancers Asia (RCA) is a multi-stakeholder research…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎥 Tomohiro Matsuda of National Cancer Center, Japan, talks on RARECAREnet-Asia: research into epidemiology of rare cancers in Asia Watch: 👉https://t.co/mbV8CqlpTu👈 #ESMOAsia22 @myESMO
-
-
Mashup Score: 0European Society for Medical Oncology - 1 year(s) ago
ESMO Congress 2021 – find out more about ESMO’s flagship portfolio and Elsevier’s Oncology Journal Network, and browse our special conference article collections
Source: www.elsevier.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Welcome to #ESMOAsia22 see our collection of papers recently published in @myesmo journals carefully selected to reflect the themes of the meeting. @Annals_Oncology @esmo_iotech @ESMO_Open View collection: https://t.co/a0nJn0GWVl https://t.co/6R2AtM50DY
-
-
Mashup Score: 0VJOncology – The video journal of oncology - 1 year(s) ago
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the awareness and understanding of oncology
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
We’ve had a fantastic few days covering #ESMOAsia22! Find coverage of the latest oncology updates and expert interviews over on https://t.co/ys1d8pDAKO 💻 🎧 @myESMO https://t.co/EU3vji5eku
-
-
Mashup Score: 1VJOncology – The video journal of oncology - 1 year(s) ago
The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the awareness and understanding of oncology
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🔈Today is the final day of #ESMOAsia22! Join us for the highlights from more exciting talks with oncology experts – and find all the latest research updates on https://t.co/ys1d8pDAKO! @myESMO https://t.co/ZgMTWJV33R
-
-
Mashup Score: 4Immunotherapy in Asian populations with hepatocellular cancer - 1 year(s) ago
New subpopulation analyses from three international phase III trials confirm efficacy of immune checkpoint inhibitors across geographical areas
Source: Daily ReporterCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#ESMOAsia22: Immunotherapy in hepatocellular carcinoma, full-population analysis of the RATIONALE-301, RATIONALE-306 and HIMALAYA studies were presented. 👉https://t.co/direceRvF8 @DrAngelaLamarca #hcc https://t.co/4A9rNIjdJa
-
🎥 Tomohiro Matsuda of National Cancer Center, Japan, talks on how to improve cancer registry systems in Asia Watch: 👉https://t.co/J0k7s4p3HT👈 #ESMOAsia22 @myESMO